KATHLEEN SCOTT: Open Payments
NPI 1720046691 · E CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 23 payments from 4 companies in 2025. Trend: 2023 $550 · 2024 $403 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $231 |
| Otsuka America Pharmaceutical, Inc. | 6 | $155 |
| ACADIA Pharmaceuticals Inc | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $123 |
Products named: VRAYLAR, REXULTI, DAYBUE, CAPLYTA.
Industry payments across OH — which companies pay providers there.
